(Q73299856)

English

Topical treatment of cutaneous chronic graft versus host disease with halofuginone: a novel inhibitor of collagen type I synthesis

scientific article published on 01 December 1999

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed ID

10609960

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10609960%20AND%20SRC:MED&resulttype=core&format=json

retrieved

2 November 2019

title

Topical treatment of cutaneous chronic graft versus host disease with halofuginone: a novel inhibitor of collagen type I synthesis (English)

1 reference

stated in

Europe PubMed Central

PubMed ID

10609960

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10609960%20AND%20SRC:MED&resulttype=core&format=json

retrieved

2 November 2019

main subject

Chronic graft versus host disease

0 references

author name string

A Nagler

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed ID

10609960

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10609960%20AND%20SRC:MED&resulttype=core&format=json

retrieved

2 November 2019

M Pines

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed ID

10609960

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10609960%20AND%20SRC:MED&resulttype=core&format=json

retrieved

2 November 2019

language of work or name

English

0 references

publication date

1 December 1999

1 reference

stated in

Europe PubMed Central

PubMed ID

10609960

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10609960%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

Europe PubMed Central

PubMed ID

10609960

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10609960%20AND%20SRC:MED&resulttype=core&format=json

retrieved

2 November 2019

volume

68

1 reference

stated in

Europe PubMed Central

PubMed ID

10609960

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10609960%20AND%20SRC:MED&resulttype=core&format=json

retrieved

2 November 2019

issue

11

1 reference

stated in

Europe PubMed Central

PubMed ID

10609960

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10609960%20AND%20SRC:MED&resulttype=core&format=json

retrieved

2 November 2019

page(s)

1806-1809

1 reference

stated in

Europe PubMed Central

PubMed ID

10609960

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10609960%20AND%20SRC:MED&resulttype=core&format=json

retrieved

2 November 2019

Identifiers

DOI

10.1097/00007890-199912150-00027

1 reference

stated in

Europe PubMed Central

PubMed ID

10609960

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10609960%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

Europe PubMed Central

PubMed ID

10609960

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10609960%20AND%20SRC:MED&resulttype=core&format=json

(Q73299856)

Topical treatment of cutaneous chronic graft versus host disease with halofuginone: a novel inhibitor of collagen type I synthesis

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)